Acute cervical radiculoplexus neuropathy contralateral to influenza vaccination preceded proximal and distal leg weakness, sensory loss and corresponding deficits of lumbosacral radiculoplexus neuropathy. Treatment with pulse corticosteroids followed by tapering oral corticosteroids and monthly low dose intravenous immune globulin was associated with eventual improvement.
References
[1]
Garten, R., Blanton, L., Abd Elal, A.I., et al. (2018) Update: Influenza Activity in the United States during the 2017-18 Season and Composition of the 2018-2019 Influenza Vaccine. Morbidity and Mortality Weekly Report, 67, 634-642.
https://doi.org/10.15585/mmwr.mm6722a4
[2]
Brauner, S., Folkersen, L., Kvarnstrom, M., et al. (2017) H1N1 Vaccination in Sjogren’s Syndrome Triggers Polyclonal B Cell Activation and Promotes Autoantibody Production. Annals of the Rheumatic Diseases, 76, 1755-1763.
[3]
Hadden, R.D.M., Collins, M.P., Zivkovic, S.A., et al. (2017) Vasculitic Peripheral Neuropathy: Case Definition for Collection Analysis, and Presentation of Immunization Safety Data. Vaccine, 35, 1567-1578.
https://doi.org/10.1016/j.vaccine.2015.11.047
[4]
Medical Research Council (1976) Aids to Examination of the Peripheral Nervous System. Memorandum No. 45. Her Majesty’s Stationary Office, London.
[5]
Dyck, P.J. and Norell, J.E. (1999) Microvasculitis and Ischemia in Diabetic Lumbosacral Radiculoplexus Neuropathy. Neurology, 53, 2113-2121.
https://doi.org/10.1212/WNL.53.9.2113
[6]
Dyck, P.J.B. and Windebank, A.J. (2002) Diabetic and Nondiabetic Lumbosacral Radiculoplexus Neuropathies: New Insights into Pathophysiology and Treatment. Muscle & Nerve, 25, 477-491. https://doi.org/10.1002/mus.10080
[7]
Dyck, P.J., Norell, J.E. and Dyck, P.J. (2001) Non-Diabetic Lumbosacral Radiculoplexus Neuropathy: Natural History, Outcome and Comparison with the Diabetic Variety. Brain, 124, 1197-207. https://doi.org/10.1093/brain/124.6.1197
[8]
Massie, R., Mauermann, M.L., Staff, N.P., Amrami, K.K., et al. (2012) Diabetic Cervical Radiculoplexus Neuropathy: A Distinct Syndrome Expanding the Spectrum of Diabetic Radiculoplexus Neuropathies. Brain, 135, 3074-3088.
https://doi.org/10.1093/brain/aws244
[9]
Collins, M.P., Dyck, P.J., Gronseth, G.S., et al. (2010) Peripheral Nerve Society Guideline on the Classification, Diagnosis, Investigation, and Immunsuppressive Therapy of Non-Systemic Vasculitis Neuropathy: Executive Summary. Journal of the Peripheral Nervous System, 15, 176-184.
https://doi.org/10.1111/j.1529-8027.2010.00281.x
[10]
Younger, D.S. (2011) Diabetic Lumbosacral Radiculoplexus Neuropathy: A Postmortem Studied Patient and Review of the Literature. Journal of Neurology, 258, 1364-1367. https://doi.org/10.1007/s00415-011-5938-8
[11]
Levy, Y., Uziel, Y., Zandman, G.G., et al. (2003) Intravenous Immunoglobulins in Peripheral Neuropathy Associated with Vasculitis. Annals of the Rheumatic Diseases, 62, 1221-1223. https://doi.org/10.1136/ard.2002.003996
[12]
Morihara, K., Arakawa, Y., Takenaka, H., Morihara, T. and Katoh, N. (2011) Systemic Lupus Erythematosus Following Vaccination against 2009 Influenza A (H1N1). Lupus, 20, 775-776. https://doi.org/10.1177/0961203310389485
[13]
Fu, M.H., Tsai, W.C., Lan, J., et al. (2014) Churg-Strauss Syndrome Following Vaccination against 2010 Influenza A (H1N1): A Case Report. Acta Neurologica Taiwanica, 23, 95-101.
[14]
Tincani, A., Andreoli, L., Cavazzana, I., et al. (2013) Novel Aspects of Sjogren’s Syndrome in 2012. BMC Medicine, 11, 93. https://doi.org/10.1186/1741-7015-11-93
[15]
Shiboski, S.C., Shiboski, C.H., Criswell, L.A., et al. (2012) American College of Rheumatology Classification Criteria for Sjogren’s Syndrome: A Data-Driven, Expert Consensus Approach in the Sjogren’s International Collaborative Clinical Alliance Cohort. Arthritis Care & Research, 64, 475-487.
https://doi.org/10.1002/acr.21591
[16]
Jamilloux, Y., Magy, L., Hurtevent, J.F., et al. (2014) Immunological Profiles Determine Neurological Involvement in Sjogren’s Syndrome. European Journal of Internal Medicine, 25, 177-181. https://doi.org/10.1016/j.ejim.2013.10.005
[17]
Mori, K., Iijima, M., Koike, H., et al. (2005) The Wide Spectrum of Clinical Manifestations in Sjogren’s Syndrome-Associated Neuropathy. Brain, 128, 2518-2534.
https://doi.org/10.1093/brain/awh605
[18]
Naddaf, E. and Dyck, P.J.B. (2015) Vasculitic Neuropathies. Current Treatment Options in Neurology, 17, 374. https://doi.org/10.1007/s11940-015-0374-1
[19]
Burns, T.M., Schaublin, G. and Dyck, P.J.B. (2007) Vasculitic Neuropathies. Neurologic Clinics, 25, 89-113. https://doi.org/10.1016/j.ncl.2006.11.002
[20]
Gorson, K.C. (2006) Therapy for Vasculitic Neuropathies. Current Treatment Options in Neurology, 8, 105-117. https://doi.org/10.1007/s11940-006-0002-1
[21]
Thaisetthawatkul, P. and Dyck, P.J.B. (2010) Treatment of Diabetic and Nondiabetic Lumbosacral Radiculoplexus Neuropathy. Current Treatment Options in Neurology, 12, 95-99. https://doi.org/10.1007/s11940-010-0059-8
[22]
Dyck, P.J. and Norell, J.E. (2001) Methylprednisolone May Improve Lumbosacral Radiculoplexus Neuropathy. Canadian Journal of Neurological Sciences, 28, 224-227. https://doi.org/10.1017/S0317167100001360
[23]
Tamburin, S. and Zanette, G. (2009) Intravenous Immunoglobulin for the Treatment of Diabetic Lumbosacral Radiculoplexus Neuropathy. Pain Medicine, 10, 1476-1480. https://doi.org/10.1111/j.1526-4637.2009.00704.x
